Oncternal Therapeutics News

Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

May 9 16:13 ET

Oncternal Therapeutics | DEFA14A: Others

Apr 26 16:23 ET

Oncternal Therapeutics | DEF 14A: Definitive information statements

Apr 26 16:20 ET

Oncternal Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 8 16:46 ET

Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Mar 7 16:17 ET

Oncternal Therapeutics | 8-K: Current report

Jan 23 00:00 ET

Oncternal Therapeutics | 8-K: Current report

Jan 5 00:00 ET

Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

Nov 9, 2023 16:15 ET

Oncternal Therapeutics | 8-K: Current report

Oct 6, 2023 16:31 ET

Oncternal Therapeutics | 8-K/A: Current report (Amendment)

Sep 14, 2023 16:01 ET

Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2023 Financial Results

Aug 10, 2023 16:11 ET

Oncternal Therapeutics | 8-K: Current report

Jun 29, 2023 06:01 ET

Oncternal Therapeutics | 8-K: Current report

Jun 2, 2023 16:31 ET

Oncternal Therapeutics | DEFA14A: Others

May 16, 2023 16:12 ET

Oncternal Therapeutics | DEF 14A: Definitive information statements

May 16, 2023 16:09 ET

Oncternal Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

May 5, 2023 16:02 ET

Oncternal Therapeutics | 8-K: Oncternal Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results

May 4, 2023 16:10 ET

Oncternal Therapeutics | 8-K: Current report

Apr 6, 2023 17:00 ET

Oncternal Therapeutics | 8-K: Current report

Apr 3, 2023 16:20 ET

Oncternal Therapeutics | 8-K/A: Current report (Amendment)

Mar 17, 2023 06:01 ET